Growth Metrics

Biogen (BIIB) Deferred Taxes (2016 - 2025)

Biogen has reported Deferred Taxes over the past 17 years, most recently at $166.9 million for Q4 2025.

  • Quarterly results put Deferred Taxes at $166.9 million for Q4 2025, up 385.79% from a year ago — trailing twelve months through Dec 2025 was $361.6 million (up 328.72% YoY), and the annual figure for FY2025 was $361.6 million, up 328.72%.
  • Deferred Taxes for Q4 2025 was $166.9 million at Biogen, down from $253.8 million in the prior quarter.
  • Over the last five years, Deferred Taxes for BIIB hit a ceiling of $323.3 million in Q4 2021 and a floor of -$607.8 million in Q2 2021.
  • Median Deferred Taxes over the past 5 years was -$39.9 million (2022), compared with a mean of -$34.9 million.
  • Biggest five-year swings in Deferred Taxes: skyrocketed 613.99% in 2021 and later plummeted 6550.0% in 2023.
  • Biogen's Deferred Taxes stood at $323.3 million in 2021, then crashed by 108.91% to -$28.8 million in 2022, then soared by 349.65% to $71.9 million in 2023, then plummeted by 181.22% to -$58.4 million in 2024, then surged by 385.79% to $166.9 million in 2025.
  • The last three reported values for Deferred Taxes were $166.9 million (Q4 2025), $253.8 million (Q3 2025), and -$31.3 million (Q2 2025) per Business Quant data.